Depreciation of Amphastar Pharmaceuticals, Inc. from 31 Dec 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Amphastar Pharmaceuticals, Inc. annual and quarterly Depreciation in USD history and change rate from 31 Dec 2012 to 31 Dec 2025.
  • Amphastar Pharmaceuticals, Inc. Depreciation for the quarter ending 31 Mar 2025 was $7,369,000, a 8.1% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. annual Depreciation for 2025 was $31,647,000, a 12% increase from 2024.
  • Amphastar Pharmaceuticals, Inc. annual Depreciation for 2024 was $28,249,000, a 12% increase from 2023.
  • Amphastar Pharmaceuticals, Inc. annual Depreciation for 2023 was $25,205,000, a 5.8% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

Amphastar Pharmaceuticals, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $31,647,000 +$3,398,000 +12% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $28,249,000 +$3,044,000 +12% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $25,205,000 +$1,390,000 +5.8% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $23,815,000 +$1,619,000 +7.3% 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025 2024 FY
2021 $22,196,000 +$1,705,000 +8.3% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
2020 $20,491,000 +$3,418,000 +20% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $17,073,000 +$2,544,000 +18% 01 Jan 2019 31 Dec 2019 10-K 11 Mar 2022 2021 FY
2018 $14,529,000 +$1,575,000 +12% 01 Jan 2018 31 Dec 2018 10-K 15 Mar 2021 2020 FY
2017 $12,954,000 +$793,000 +6.5% 01 Jan 2017 31 Dec 2017 10-K 16 Mar 2020 2019 FY
2016 $12,161,000 +$847,000 +7.5% 01 Jan 2016 31 Dec 2016 10-K 15 Mar 2019 2018 FY
2015 $11,314,000 -$1,214,000 -9.7% 01 Jan 2015 31 Dec 2015 10-K 14 Mar 2018 2017 FY
2014 $12,528,000 +$1,357,000 +12% 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2017 2016 FY
2013 $11,171,000 +$1,514,000 +16% 01 Jan 2013 31 Dec 2013 10-K 15 Mar 2016 2015 FY
2012 $9,657,000 01 Jan 2012 31 Dec 2012 10-K 26 Mar 2015 2014 FY

Amphastar Pharmaceuticals, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $7,369,000 +$553,000 +8.1% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $6,816,000 +$564,000 +9% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $6,252,000 +$637,000 +11% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q1 2022 $5,615,000 -$71,000 -1.2% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q1 2021 $5,686,000 +$970,000 +21% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q1 2020 $4,716,000 +$558,000 +13% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q1 2019 $4,158,000 +$1,098,000 +36% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q1 2018 $3,060,000 -$40,000 -1.3% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q1 2017 $3,100,000 +$153,000 +5.2% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q1 2016 $2,947,000 +$176,000 +6.4% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q1 2015 $2,771,000 -$169,000 -5.7% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q1
Q1 2014 $2,940,000 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015 2015 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.